EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evidence that 5 hydroxy tryptamine agonist induced rotational behavior in the rat is mediated via 5 hydroxy tryptamine 2 receptors


Psychopharmacology 83(2): 163-166
Evidence that 5 hydroxy tryptamine agonist induced rotational behavior in the rat is mediated via 5 hydroxy tryptamine 2 receptors
The rotational behavior induced by 5-HT agonists was investigated in rats with lesions of the dorsal raphe' nucleus (DRN). 5-Methoxy-N,N-dimethyltryptamine (5-MeODMT) caused dose-related contralateral rotation in rats with 5,7-dihydroxytryptamine (5,7-DHT) lesions of the DRN. Similar findings were presented for the 5-HT1 agonists 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and 5-methoxy-3 (1,2,3,6-tetrahydropyridin-4-yl) (1H indole) (RU24969). In this model, in agreement with the behavioral studies, both agonists had a greater affinity for the 5-HT1 binding site when compared with the 5-HT2 binding site. Antagonist studies using selective 5-HT2 antagonists (ketanserin and pirenperone) at non-sedative doses failed to inhibit this behavior. The classical 5-HT antagonist methysergide caused significant inhibition of the rotational behavior. 5-HT agonist-induced rotation in the rat is apparently mediated via 5-HT1 receptors, probably located in the substantia nigra.


Accession: 005411960



Related references

Rotational behavior elicited by 5 hydroxy tryptamine in the rat evidence for an inhibitory role of 5 hydroxy tryptamine in the substantia nigra and corpus striatum. Journal of Pharmacy & Pharmacology 32(3): 196-200, 1980

The mechanisms by which clenbuterol a beta adrenoceptor agonist enhances 5 hydroxy tryptamine mediated behavior and increases metabolism of 5 hydroxy tryptamine in the brain of the rat. Neuropharmacology 22(6): 739-750, 1983

Evidence for common pharmacological properties of tritium labeled 5 hydroxy tryptamine binding sites presynaptic 5 hydroxy tryptamine auto receptors in central nervous system and inhibitory presynaptic 5 hydroxy tryptamine receptors on sympathetic nerves. Naunyn-Schmiedeberg's Archives of Pharmacology 324(2): 116-124, 1983

Is hyper loco motion induced by the 5 hydroxy tryptamine 1 agonist ru 24969 5 methoxy 3 1 2 3 6 tetrahydropyridin 4 yl 1h indole mediated by the 5 hydroxy tryptamine 1 receptor. British Journal of Pharmacology 81(SUPPL): 140P, 1984

The effects of lesions produced by 5 7 di hydroxy tryptamine on 5 hydroxy tryptamine mediated behavior induced by amphetamine in large doses in the rat. Neuropharmacology 23(4): 423-430, 1984

Evidence for mediation by 5 hydroxy tryptamine 2 receptors of 5 hydroxy tryptamine induced contraction of canine basilar artery. Naunyn-Schmiedeberg's Archives of Pharmacology 324(4): 287-292, 1983

The effects of chronic treatment with the 5 hydroxy tryptamine uptake blocker zimelidine on central 5 hydroxy tryptamine mechanisms evidence for the induction of a low affinity binding site for 5 hydroxy tryptamine. Neuroscience Letters 13(3): 307-312, 1979

5 hydroxy tryptaminergic control of red pigment dispersing hormone release in the fiddler crab uca pugilator effects of a 5 hydroxy tryptamine uptake inhibitor and a 5 hydroxy tryptamine receptor blocker on 5 hydroxy tryptamine induced and iproniazid induced red pigment dispersion. General & Comparative Endocrinology 45(3): 395-401, 1981

Lack of effect of the putative central 5 hydroxy tryptamine agonist 8 hydroxy 2 di n propylamino tetralin on the 5 hydroxy tryptamine auto receptor. Naunyn-Schmiedeberg's Archives of Pharmacology 324(SUPPL): R19, 1983

Effects of methysergide and 5 hydroxy tryptamine on carotid blood flow distribution in pigs further evidence for the presence of atypical 5 hydroxy tryptamine receptors. British Journal of Pharmacology 82(4): 817-826, 1984